The Clinical Research Training Institute in Latin America is intended for fellows and early to mid-career hematology faculty working in Latin American countries who are engaged in clinical research and training.
Peter M. Voorhees, MD, discusses the 5-year follow-up results from the CARTITUDE-1 trial of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.
The 18th International Conference on Malignant Lymphoma (18-ICML) took place in Lugano, Switzerland, on 17-21 June, 2025. This meeting brought together lymphoma experts from around…
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Orlando World Center Marriott • Orlando, FL | Virtual attendance also available Friday, April 5, 2024 – Sunday, April 7, 2024 | Nursing Program Educational…
Clinical Research Training Institute MMENA
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
Ilana Cass, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, discusses subgroup analyses from the RUBY trial (NCT03981796) evaluating time to first and second subsequent therapy (TFST/TSST)…
An abstract is unavailable.
Key PointsAlthough rare, critical ITP bleeding was fatal (47% of adults; 15% of children), with higher mortality in older cases and delayed treatment.The c
David Spigel, MD, discusses the pivotal findings from the AIM-HIGH trial in early-stage non-squamous NSCLC.
